UNIT FOUR TEST

1
UNIT FOUR TEST 2

• REVIEW CH. 19-20
• CH. 25-27

2
Key points

• Angina pectoris
• s/s of angina
• Types of angina
• Treatment goals for angina
• Pathophysiology of angina
• What has become the standard drug tx of angina?
• Six groups of drugs to tx angina

3

• Therapy to prevent MI
• DRUG CLASS NITRATES
• Action
• NTG-drug of choice
• Tolerance of NTG
• Administration of NTG---SL, sustained released
  tablets, translingual spray
• Medication deterioration/accessibility

4

• DRUG CLASS BETA BLOCKERS
• Actions
• TREATMENT OF PVD
• NURSING PROCESS
• Assessment, hx of risk factors, dietary habits,
  assessment of tissue
• DRUG CLASS Hemorrheologic agent
• PENTOXIFYLLINE/TRENTAL
• ACTIONS

5

• TRENTAL cont.
• Drug interactionsantihypertensive agents
• DRUG CLASS vasodilators
• ISOXSUPRINE/VASODILAN
• ACTIONS
• SIDE EFFECTS TO EXPECT
• SIDE EFFECTS TO REPORT

6

• MAJOR CAUSES OF THROMBUS FORMATION
• DISEASES CAUSED BY INTRAVASCULAR CLOTTING
• DRUG THERAPY ACTIONS USED TO TX THROMBOEMBOLIC
  DZ.
• NURSING PROCESS FOR ANTICOAGULANT THERAPY--
• TECHNIQUES FOR PREVENTING CLOT FORMATION

7

• ANTICOAGULANT THERAPY cont.
• ASSESS NUTRITIONAL STATUS
• MEDICATION REGIMEN
• S/S TO REPORT OF ANTICOAGULANT THERAPY
• DRUG CLASSPLATELET INHIBITORS
• PERSANTINE
• USES OF PERSANTINE

8

• LOVENOX/ENOXAPARIN
• USES
• NURSING PROCESS
• HOW TO GIVE
• PT. TEACHING

9

• HEPARIN
• USES
• NURSING PROCESS FOR HEPARIN
• DOSAGE/ADMINISTRATION
• NORMAL THERAPEUTIC RANGES
• HOW TO GIVE
• ROUTES OF ADMINISTRATION
• ANTIDOTE

10

• COUMADIN
• ACTIONS
• DOSAGE/IMPLEMENTATION
• ANTIDOTE
• SIDE EFFECTS TO REPORT
• SPECIAL PT TEACHING FOR FEMALES
• DRUG CLASS FIBRINOLYTIC AGENTS
• ACTIONS